This Government Contract opportunity from Department Of Health And Human Services was posted on June 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institute on Aging, through its Center for Alzheimer’s Disease and Related Dementias, intends to award a sole source firm-fixed-price contract to The Jackson Laboratory for the expansion, quality control, curation, biobanking, and public distribution of up to 936 isogenic induced pluripotent stem cell lines supporting the iPSC Neurodegenerative Disease Initiative. The requirement includes 486 female SNV lines and 450 additional lines derived from 25 high-priority SNV trios across six engineered cell lines, all developed using CRISPR-Cas12a technology based on gene variants provided by the government. The contractor must expand and validate each line according to strict iNDI protocols, which mandate post-thaw viability exceeding 80% for manual expansion or 50% confluency within 10 days for automated expansion, negative sterility results across bacterial, fungal, viral, and mycoplasma panels, confirmation of intended genetic edits via PCR and Sanger sequencing, absence of reprogramming vectors, normal karyotype via SNP-based digital karyotyping, and pluripotency marker expression confirmed by RNA sequencing. Each cell line must be accompanied by comprehensive quality control documentation and curated product web content, with all lines made available for public purchase through a contractor-hosted platform that maintains continuity with existing iNDI resources. The contract includes a base year from September 1, 2026, through August 31, 2027, and three optional one-year extensions through August 31, 2030, with performance to occur exclusively at The Jackson Laboratory’s facility in Bar Harbor, Maine. The authority for sole source acquisition is based on 41 U.S.C. 1901 and FAR 6.302-1, as The Jackson Laboratory is the only known entity capable of delivering the required cell lines and infrastructure, having previously executed similar iNDI tasks and maintaining the existing distribution platform. The government has issued a notice of intent and invites capability statements from other responsible sources by June 23, 2026, to evaluate potential for competition, though no competitive solicitation is currently planned. Responses must include company identification, UEI and CAGE codes, business size and socioeconomic status, technical point of contact details, a narrative demonstrating capability to meet all technical requirements, and relevant past performance evidence, all submitted electronically to the designated contracting officers.
General Info
Agency
NAICS
Place of Performance
Bar Harbor, ME, 04609, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
SPECIAL NOTICE
NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT
Agency: Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Aging (NIA)
Office: Center for Alzheimer’s Disease and Related Dementias (CARD)
Notice Type: Special Notice
Notice Number: NIH-NOI-26-PCA-NIA-01205
Title: Notice of Intent to Sole Source – iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project
NAICS Code: 325414 – Biological Product (except Diagnostic) Manufacturing
PSC: 6550 – In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Description
This is a notice of intent to award a sole source contract and is not a request for competitive quotations, proposals, or bids. The National Institute on Aging (NIA), Center for Alzheimer’s Disease and Related Dementias (CARD), intends to negotiate and award a firm-fixed-price contract to:
The Jackson Laboratory
600 Main Street
Bar Harbor, ME 04609
UEI: XR6LMXNKDJJ1
for iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) Project.
The anticipated contract will provide for the expansion, quality control, curation, biobanking, and distribution of up to 936 isogenic Alzheimer’s disease and related dementias (ADRD) induced pluripotent stem cell (iPSC) lines in support of the iPSC Neurodegenerative Disease Initiative (iNDI). The requirement includes:
- FA13.1J female SNV lines totaling 486 iPSC lines;
- 25 high-priority SNV trios across six additional iPSC lines totaling 450 iPSC lines;
- expansion and quality control in accordance with current iNDI protocols;
- product and web content creation for each iPSC line; and
- public distribution of cell lines through an established contractor-hosted website/platform.
The statutory authority for this acquisition is 41 U.S.C. 1901, as implemented by FAR 13.501(a)(1)(ii), based on the circumstances described in FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
The Government’s market research included review of the prior sources sought notice posted on SAM.gov under Notice ID 75N95025Q00209-SBSS, review of prior NIH awards for similar iNDI requirements, and review of commercially available information regarding potential sources. Based on that market research, The Jackson Laboratory is the only known source capable of providing the specific iNDI FA13.1J iPSC cell lines and associated expansion, quality control, curation, and distribution services required for this acquisition. The Jackson Laboratory also maintains the existing iNDI distribution infrastructure and has successfully performed prior related iNDI requirements for NIH.
Period of Performance
- Base Year: September 1, 2026 – August 31, 2027
- Option Year 1: September 1, 2027 – August 31, 2028
- Option Year 2: September 1, 2028 – August 31, 2029
- Option Year 3: September 1, 2029 – August 31, 2030
Place of Performance
The principal place of performance is the contractor’s facility.
Responses
This notice is not a solicitation. However, any responsible source that believes it can satisfy the Government’s requirement may submit a capability statement for the Government’s consideration. Capability statements shall clearly demonstrate the ability to provide:
- the specific iNDI FA13.1J cell lines and associated iNDI lines required under this acquisition;
- expansion and quality control in accordance with current iNDI protocols;
- product and web content creation for each iPSC line;
- public distribution through an established contractor-hosted platform; and
- continuity sufficient to preserve comparability with existing iNDI resources and prior work.
Responses shall include, at a minimum:
- Company name
- UEI and CAGE Code, if applicable
- Business size and socioeconomic status
- Technical point of contact, including name, title, telephone number, and email address
- Narrative capability statement addressing the requirements above
- Relevant past performance information for similar efforts
Responses must be submitted electronically to the point(s) of contact below no later than June 23, 2026, 11:00 am EST. Responses received after the stated deadline may not be considered.
The Government will review all timely responses solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government will not be responsible for any costs incurred by respondents in preparing or submitting a response.
Point(s) of Contact
Primary Point of Contact: Linda Smith, Contracting Officer, linda.smith2@nih.gov
Secondary Point of Contact: Danielle Tines, Procurement Technician, danielle.tines@nih.gov
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS